These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10676114)

  • 1. [Nephropathy: current aspects and therapeutic prospects].
    Savazzi G
    Recenti Prog Med; 1999 Dec; 90(12):685-7. PubMed ID: 10676114
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.
    Suzuki H
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):397-405. PubMed ID: 19491138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
    Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
    Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of angiotensin converting enzyme inhibitors in nephrology].
    Stefanović V; Ivić M; Bogićević M
    Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of infants born to women with chronic kidney disease.
    Blowey DL; Warady BA
    Adv Chronic Kidney Dis; 2007 Apr; 14(2):199-205. PubMed ID: 17395122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Further evidence for the renoprotective effect of ACE inhibitors: ramipril protects against the progression of chronic renal insufficiency in non-diabetic nephropathy with nephrotic proteinuria].
    Mayr M; Dickenmann MJ
    Schweiz Med Wochenschr; 2000 Apr; 130(13):491. PubMed ID: 10812646
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
    Savin M; Petronić V
    Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halting the progression of renal disease: where we stand?
    Campbell RC; Remuzzi G
    Nefrologia; 2002; 22(4):303-5. PubMed ID: 12369119
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
    Swislocki AL; Siegel D
    Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F; Rangoonwala B
    Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrology.
    Chertow GM
    JAMA; 1997 Jun; 277(23):1872-3. PubMed ID: 9185809
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension and progression of renal disease.
    Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
    J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current prospects in nephrology].
    Migone L
    Minerva Nefrol; 1979; 26(4):449-58. PubMed ID: 396487
    [No Abstract]   [Full Text] [Related]  

  • 16. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrology 2005/2006. Recent clinical studies and developments in science].
    Floege J
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1445-8. PubMed ID: 16794972
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.
    Myers BD; Boothroyd D; Olshen RA
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S66-70. PubMed ID: 11443771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.